Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Marinus Pharma CS
(NQ:
MRNS
)
1.435
+0.025 (+1.77%)
Streaming Delayed Price
Updated: 11:22 AM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
688,878
Open
1.400
Bid (Size)
1.430 (17)
Ask (Size)
1.440 (9)
Prev. Close
1.410
Today's Range
1.400 - 1.490
52wk Range
1.120 - 11.26
Shares Outstanding
54,642,580
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024
Today 8:00 EDT
From
Marinus Pharmaceuticals
Via
Business Wire
How Is The Market Feeling About Marinus Pharma?
April 29, 2024
Via
Benzinga
Performance
YTD
-86.20%
-86.20%
1 Month
-84.00%
-84.00%
3 Month
-85.64%
-85.64%
6 Month
-79.32%
-79.32%
1 Year
-84.27%
-84.27%
More News
Read More
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
April 17, 2024
Via
Benzinga
Analysts Question Commercial Viability of Marinus' IV Ganaxolone After Interim Analysis Miss
April 16, 2024
Via
Benzinga
The Latest Analyst Ratings For Marinus Pharma
April 16, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Marinus Pharma Through Analyst Insights
March 26, 2024
Via
Benzinga
Leverage Shares -3x Short Moderna (MRNA) ETP Securities: Q4 Earnings Insights
March 05, 2024
Via
Benzinga
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
April 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 15, 2024
Via
Benzinga
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
April 15, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
April 15, 2024
Via
Benzinga
Why Are Stocks Up Today?
April 15, 2024
Via
InvestorPlace
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
April 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
DJT Stock Alert: Trump Media Plunges on Share Sale Panic
April 15, 2024
Via
InvestorPlace
Topics
Government
Exposures
Political
Why Is Marinus Pharmaceuticals (MRNS) Stock Down 79% Today?
April 15, 2024
Via
InvestorPlace
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
April 15, 2024
From
Schall Law
Via
GlobeNewswire
Why Did Epilepsy/Seizure Focused-Marinus Pharmaceuticals Stock Hit 52-Week Low On Monday?
April 15, 2024
Via
Benzinga
Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings
April 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 15, 2024
Via
Benzinga
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
April 15, 2024
From
Marinus Pharmaceuticals
Via
Business Wire
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
April 05, 2024
From
Marinus Pharmaceuticals
Via
Business Wire
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review
March 27, 2024
From
Marinus Pharmaceuticals
Via
Business Wire
MRNS Stock Earnings: Marinus Pharma Misses EPS, Misses Revenue for Q4 2023
March 05, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 05, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.